Sept 17 (Reuters) - Vectus Biosystems Ltd (VBS) :
- ANNOUNCES A SUCCESSFUL CONVERTIBLE NOTE ISSUE TO RAISE AN AMOUNT OF $7 MILLION
- FUNDS WILL BE USED TO COMPLETE PHASE I CLINICAL TRIALS FOR VB0004, WHICH POTENTIALLY PREVENTS & REVERSES FIBROSIS IN ORGANS
News: VBS Vectus Biosystems Announces Successful Convertible Note Issue To Raise $7 Million
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add VBS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.260M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| VBS (ASX) Chart |
Day chart unavailable